Baylor St. Luke's Medical Center
   Execute Search
LVAD Program

(832) 355-4100

Find A Doctor
LVAD program, transplant hospital
images courtesy Thoratec Corporation, Inc.

LVAD Program

For more information on our LVAD Program or to schedule your first appointment:
To speak to an LVAD Representative:
Toll Free
International Patients

View a map of our location

Latest Transplant News

The Left Ventricular Assist Device (LVAD) Program at CHI St. Luke's Health - Baylor St. Luke’s Medical Center, home of the Texas Heart® Institute, is one of the most experienced, successful programs in the world.  Our surgeons have performed more than 1,000 LVAD procedures.  The key to the program’s success is an experienced, highly skilled team that includes surgeons, cardiologists, LVAD coordinators, staff nurses, operating room personnel, social workers, dieticians, rehabilitation specialists, and many other professionals.


  1975 First study funded by the National Heart, Lung and Blood Institute of an implantable left ventricular assist device (LVAD) for post-cardiotomy support
  1978 First bridge-to-transplant with an LVAD
  1988 First implantable continuous flow LVAD implanted – The Hemopump developed at the Texas Heart® Institute
  1991 First patient in the world discharged from the hospital with an electric, portable, battery-powered LVAD
  1994 FDA approval to use the HeartMate® Pneumatic LVAD as a bridge to transplantation (BTT), a treatment option for patients with advanced-stage heart failure
  1996 FDA approval to use the HeartMate® Vented Electric as a bridge to transplantation (BTT)
  2000 First site for clinical trials of the Jarvik 2000, a miniature, axial flow left ventricular assist device
  2001 Completed REMATCH study, which compared long-term implantation of the HeartMate® VE LVAD to conventional medical therapy for heart failure
  2002 HeartMate® VE LVAD approved for destination therapy
  2003 First implantation in the U.S. of the clinical HeartMate® II LVAD; currently the most widely used continuous flow LVAD in the world.
  2004 First patient in the U.S. to receive HeartMate® II LVAD surpasses one year of survival with the device
  2008 HeartMate® II Left Ventricular Assist System (LVAD) received FDA approval as a bridge-to-transplant (BTT) treatment option for patients suffering from advanced-stage heart failure
 2009HeartWare® LVAD Clinical trial 
  2010 FDA approves HeartMate® II LVAD as Destination Therapy (DT)

HeartWare® received FDA approval for bridge to transplant (BTT) option


The Texas Heart® Institute at CHI St. Luke's Health - Baylor St. Luke's Medical Center
The Heart Exchange Transplant Support Group
Donate Life Texas
Donate Life America
Lodging close to CHI St. Luke's Health - Baylor St. Luke's Medical Center
Parking close to CHI St. Luke's Health - Baylor St. Luke's Medical Center
LVAD and Heart Pumps

Kidney Transplant Program
Liver Transplant Program
Heart Transplant Program